Leveraging innovative platforms and with a combined 35 years of CRO experience we are supporting scientific advancement from translational science to clinical research and diagnostics. At LuminoDx we specialize in acquiring and leveraging cutting-edge technologies for protein and molecular analysis. This includes Olink’s proteomic platform, Biotechne’s ELLA elisa system, ELEMENT Bio’s Aviti-24 sequencing and multiomics platform, multiple PCR technologies, and our own proprietary single step microRNA analysis platform.
Leading the Way in Advanced Translational and Clinical Research Services
At LuminoDx, we are an experienced team, motivated by a passion for using scientific innovations to successfully support therapeutic development. We offer best in class next gen liquid biopsy solutions including exosome isolation, and advanced clinical testing. By leading the way in next-gen liquid biopsy biomarker discovery and development, we are helping to shape the future of precision diagnostics.
Top-quality data, guaranteed.
We provide services from biomarker discovery to the commercialization of the test.